| Literature DB >> 29652789 |
Guo-Fei Qin1,2, Xu-Li Tang3, Yan-Ting Sun4,5, Xiang-Chao Luo6,7, Jing Zhang8,9, Leen van Ofwegen10, Ping-Jyun Sung11,12, Ping-Lin Li13,14, Guo-Qiang Li15,16.
Abstract
Three new sesquiterpenoids (sinuketal (1), sinulins A and B (2 and 3)) and two new cembranoids (sinulins C and D (4 and 5)), as well as eight known sesquiterpenoids (6–13) and eight known cembranoids (14–21), were isolated from the Xisha soft coral Sinularia sp. Their structures were elucidated by extensive spectroscopic analysis. Compound 1 possesses an unprecedented isopropyl-branched bicyclo [6.3.0] undecane carbon skeleton with unique endoperoxide moiety, and a plausible biosynthetic pathway of it was postulated. According to the reported biological properties of endoperoxide, the antimalarial, cytotoxic, antiviral, and target inhibitory activities of 1 were tested. Compound 1 showed mild in vitro antimalarial activity against Plasmodium falciparum 3D7, weak cytotoxic activities toward Jurkat, MDA-MB-231, and U2OS cell lines, inhibitory effects against influenza A viruses H1N1 and PR8, as well as mild target inhibitory activity against acetylcholinesterase. The other compounds were evaluated for cytotoxicities against HeLa, HCT-116, and A549 tumor cell lines and target inhibitory activities against protein tyrosine phosphatase 1B (PTP1B). Compound 20 exhibited cytotoxicities against HeLa and HCT-116, and compounds 5, 11, and 15 showed mild target inhibitory activities against PTP1B.Entities:
Keywords: Sinularia sp.; antimalarial; antiviral; cembranoid; cytotoxicities; sesquiterpenoid; soft coral; targets inhibitory activities
Mesh:
Substances:
Year: 2018 PMID: 29652789 PMCID: PMC5923414 DOI: 10.3390/md16040127
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Structures of compounds 1–5.
NMR spectral data of compound 1.
| No. | 1H-1H COSY | HMBC | NOE | ||
|---|---|---|---|---|---|
| 1a | 1.72 (1H, m) | 28.0 (CH2) | H-1b, 11 | C-2, 3, 10 | - |
| 2 | 1.80 (2H, m) | 33.2 (CH2) | H-1a | C-1, 3, 10, 11 | - |
| 3 | - | 98.0 (C) | - | - | - |
| 4 | 3.14 (1H, d, 13.4) | 49.2 (CH2) | H-4 | C-6, 10 | H-9 |
| 5 | - | 107.4 (C) | - | - | - |
| 6 | 1.92 (1H, td, 13.2, 4.2) | 39.3 (CH2) | H-6 | C-5, 7, 8 | - |
| 7 | 2.29 (1H, m) | 29.1 (CH2) | H-6 | C-5, 6, 8, 9, 15 | - |
| 8 | - | 149.4 (C) | - | - | - |
| 9 | 2.04 (1H, m) | 40.8 (CH2) | H-9 | C-3, 7, 8, 10, 11, 15 | H-4 |
| 10 | 2.39 (1H, m) | 46.8 (CH) | H-9 | C-3, 9, 11, 12 | H-9 |
| 11 | 1.31 (1H, m) | 54.3 (CH) | H-1a, 10, 12 | C-1, 9, 10, 12, 13, 14 | H-9 |
| 12 | 1.65 (1H, m) | 32.8 (CH) | H-11, 13, 14 | C-1, 10, 11, 13, 14 | H-10 |
| 13 | 0.95 (3H, d, 6.7) | 22.0 (CH3) | H-12 | C-11, 12, 14 | H-10 |
| 14 | 0.89 (3H, d, 6.7) | 20.1 (CH3) | H-12 | C-11, 12, 13 | - |
| 15a | 4.90 (1H, brs) | 113.0 (CH2) | H-9 | C-7, 9 | - |
a Spectrum recorded at 500 MHz in CDCl3. b Spectrum recorded at 125 MHz in CDCl3.
Figure 21H-1H COSY and selected key HMBC correlations of 1–5.
Figure 3Key NOE correlations of 1–5.
Figure 4(a) Correlation of experimental and calculated chemical shifts of 1a; (b) experimental and theoretical ECD spectra of 1.
Scheme 1Plausible biosynthetic pathway of 1.
NMR spectral data of compound 2.
| No. | 1H-1H COSY | HMBC | NOE | ||
|---|---|---|---|---|---|
| 1 | 1.91 (1H, m) | 23.9 (CH2) | H-2, 10 | C-2, 9, 10 | - |
| 2 | 2.24 (1H, m) | 33.3 (CH2) | H-1 | C-1, 3, 14 | - |
| 3 | - | 60.3 (C) | - | - | - |
| 4 | - | 213.2 (C) | - | - | - |
| 5 | 2.56 (1H, ddd, 13.5, 7.0, 2.5) | 38.0 (CH2) | H-6 | C-4, 6, 7 | - |
| 6 | 3.00 (1H, ddd, 15.6, 7.1, 3.2) | 20.1 (CH2) | H-5 | C-4, 5, 7, 8, 15 | - |
| 7 | - | 143.7 (C) | - | - | - |
| 8 | 6.78(1H, dd, 4.8, 1.8) | 157.4 (CH) | H-9 | C-3, 6, 9, 10, 15 | - |
| 9 | 2.48 (1H, dd, 10.4, 4.3) | 49.0 (CH) | H-8, 10 | C-3, 4, 7, 8, 10, 11 | H-14 |
| 10 | 2.08 (1H, m) | 49.4 (CH) | H-1, 9, 11 | C-1, 8, 9, 11, 12, 13 | H-14 |
| 11 | 1.67 (1H, m) | 31.5 (CH) | H-10, 12, 13 | C-1, 9, 10, 12, 13 | - |
| 12 | 0.88 (3H, d, 6.7) | 18.9 (CH3) | H-11 | C-10, 11, 13 | - |
| 13 | 0.93 (3H, d, 6.7) | 21.5 (CH3) | H-11 | C-10, 11, 12 | - |
| 14 | 1.02 (3H, s) | 19.5 (CH3) | - | C-2, 3, 4, 9 | H-9, 10 |
| 15 | 9.49 (1H, s) | 192.7 (CH) | - | C-6, 7 | - |
a Spectrum recorded at 500 MHz in CDCl3. b Spectrum recorded at 125 MHz in CDCl3.
Figure 5(a) Experimental and theoretical ECD spectra of 2; (b) experimental and theoretical ECD spectra of 3.
NMR spectral data of compound 3.
| No. | 1H-1H COSY | HMBC | NOE | ||
|---|---|---|---|---|---|
| 1 | - | 213.0 (C) | - | - | - |
| 2 | 2.66 (1H, m) | 38.3 (CH2) | H-3 | C-1, 3 | - |
| 3 | 2.60 (1H, m) | 35.3 (CH2) | H-2 | C-1, 2, 4, 5, 15 | - |
| 4 | - | 142.9 (C) | - | - | - |
| 5 | 2.21 (1H, d, 9.9) | 54.9 (CH) | H-6 | C-1, 3, 4, 6, 9, 10, 14, 15 | H-7 |
| 6 | 4.17 (1H, dd, 9.9, 9.9) | 68.7 (CH) | H-5, 7 | C-4, 5, 7, 11 | H-13, 14 |
| 7 | 1.55 (1H, td, 9.6, 3.5) | 52.7 (CH) | H-6, 8 | C-6, 8, 11 | H-5 |
| 8 | 1.73 (1H, ddd, 10.5, 6.6, 3.3) | 21.9 (CH2) | H-7, 9 | C-7, 10 | - |
| 9 | 1.78 (1H, dt, 13.7, 3.0) | 31.5 (CH2) | H-8 | C-8, 10 | - |
| 10 | - | 49.8 (C) | - | - | - |
| 11 | - | 74.6 (C) | - | - | - |
| 12 | 1.26 (3H, s) | 30.0 (CH3) | - | C-7, 11, 13 | - |
| 13 | 1.30 (3H, s) | 24.1 (CH3) | - | C-7, 11, 12 | H-6 |
| 14 | 1.01 (3H, s) | 17.9 (CH3) | - | C-1, 5, 9, 10 | H-6 |
| 15 | 5.28 (1H, s) | 110.6 (CH2) | H-5 | C-3, 4, 5 | - |
a Spectrum recorded at 500 MHz in CDCl3. b Spectrum recorded at 125 MHz in CDCl3.
NMR spectral data of compound 4.
| No. | 1H-1H COSY | HMBC | NOESY | ||
|---|---|---|---|---|---|
| 1 | 2.49 (1H, m) | 44.1 (CH) | H-2, 14 | C-2 | H-9 |
| 2 | 3.12 (1H, dd, 15.1, 3.0) | 30.6 (CH2) | H-1 | C-1, 3, 4, 14, 15 | - |
| 3 | - | 161.0 (C) | - | - | - |
| 4 | - | 114.6 (C) | - | - | - |
| 5 | 6.63 (1H, s) | 112.2 (CH) | - | C-3, 4, 6 | H-19 |
| 6 | - | 149.0 (C) | - | - | - |
| 7 | 4.07 (1H, s) | 83.7 (CH) | - | C-5, 8, 9, 19, 22 | H-5, 19 |
| 8 | - | 73.1 (C) | - | - | - |
| 9 | 2.47 (1H, d, 17.8) | 46.0 (CH2) | - | C-7, 8, 10, 19 | H-19 |
| 10 | - | 208.6 (C) | - | - | - |
| 11a | 3.60 (1H, d, 18.2) | 42.0 (CH2) | - | C-10, 12, 13, 20 | - |
| 12 | - | 125.1 (C) | - | - | - |
| 13 | 6.96 (1H, dd, 11.0, 4.0) | 144.1 (CH) | H-14 | C-1, 11, 14, 20 | - |
| 14a | 2.45 (1H, m) | 31.4 (CH2) | H-1, 13 | C-1, 2, 12, 13, 15 | H-11 |
| 15 | - | 145.9 (C) | - | - | - |
| 16 | 4.87 (1H, s) | 111.4 (CH2) | H-17 | C-1, 15, 17 | - |
| 17 | 1.81 (3H, s) | 20.8 (CH3) | H-16 | C-1, 15, 16 | - |
| 18 | - | 164.0 (C) | - | - | - |
| 19 | 1.35 (3H, s) | 27.9 (CH3) | - | C-7, 8, 9 | H-7, 9 |
| 20 | - | 167.3 (C) | - | - | - |
| 21 | 3.79 (3H, s) | 51.4 (-OCH3) | - | C-18 | - |
| 22 | 3.26 (3H, s) | 57.8 (-OCH3) | - | C-7 | - |
| 23 | 3.72 (3H, s) | 52.1 (-OCH3) | - | C-20 | - |
a Spectrum recorded at 500 MHz in CDCl3. b Spectrum recorded at 125 MHz in CDCl3.
NMR spectral data of compound 5.
| No. | 1H-1H COSY | HMBC | NOESY | ||
|---|---|---|---|---|---|
| 1 | 2.90 (1H, m) | 38.9 (CH) | H-2, 14 | C-2 | H-2 |
| 2 | 2.70 (1H, m) | 44.3 (CH2) | H-1 | C-1, 3, 4 | - |
| 3 | - | 207.1 (C) | - | - | - |
| 4 | 2.80 (1H, m)2.39 (1H, m) | 46.5 (CH2) | H-5 | C-3, 5 | H-5, 2 |
| 5 | 4.32 (1H, brd, 11.1) | 76.8 (CH) | H-4 | C-3, 4, 6 | H-4 |
| 6 | - | 212.1 (C) | - | - | - |
| 7 | 2.67 (1H, m) | 48.8 (CH2) | - | C-6, 8, 9, 18 | H-5 |
| 8 | - | 79.8 (C) | - | - | - |
| 9 | 2.82 (1H, m) | 50.7 (CH2) | - | C-7, 8, 10, 18 | - |
| 10 | - | 205.7 (C) | - | - | - |
| 11a | 3.51 (1H, d, 17.6) | 43.5 (CH2) | - | C-10, 12, 13, 19 | - |
| 12 | - | 128.6 (C) | - | - | - |
| 13 | 6.80 (1H, dd, 7.0, 7.0) | 140.9 (CH) | H-14 | C-1, 11, 12, 19 | - |
| 14 | 2.27 (2H, m) | 28.8 (CH2) | H-1, 13 | C-1, 2, 12, 13, 15 | H-11b |
| 15 | - | 144.9 (C) | - | - | - |
| 16a | 4.95 (1H, s) | 112.2 (CH2) | H-17 | C-1, 15, 17 | - |
| 17 | 1.75 (CH3, s) | 21.2 (CH3) | - | C-1, 15, 16 | - |
| 18 | 1.41 (CH3, s) | 27.5 (CH3) | - | C-7, 8, 9 | H-7 |
| 19 | - | 167.3 (C) | - | - | - |
| 20 | 3.71 (CH3, s) | 52.0 (CH3) | - | C-19 | - |
a Spectrum recorded at 500 MHz in CDCl3. b Spectrum recorded at 125 MHz in CDCl3.
Figure 6Structures of compounds 6–21.